The Therapeutic Goods Administration (TGA) of Australia has prepared clinical guidance documents for prescribers of medicinal cannabis products for numerous conditions. A link to the guidance document for epilepsy can be found here.

Additional clinical evidence that has been published since the release of the TGA’s guidance documents is being developed into summaries that will be available soon.